Scientific Strategic Plan

Scientific Strategic Plan published in Nature Medicine  
Scientific Strategic Plan and Working Group Reports   
Scientific Strategic Plan press release  
Scientific Strategic Plan FAQ  

The cornerstone of the Global HIV Vaccine Enterprise is its Scientific Strategic Plan (the Plan), a collaborative framework to accelerate HIV vaccine research and development. The first Enterprise Scientific Strategic Plan was published in 2005.

Developed by the Enterprise Council and informed by more than 400 researchers, policy-makers, funders and advocates worldwide, the Plan presents a shared vision and strategy to transform recent scientific advancements and the momentum and opportunities of the past five years into faster, smarter and more productive research to accelerate the search for an HIV vaccine. The Plan defines critical roadblocks, as well as opportunities that would benefit from increased global cooperation, and is designed to complement and build on the independent research efforts and discoveries of Enterprise members worldwide. The Plan articulates the commitment of Enterprise partners to work toward aligning their strategies and activities to help realize a shared vision for the field.

To develop the 2010 Plan, the Enterprise Council in January 2009 initiated a broad consultative process to update the 2005 Plan to reflect the anticipated challenges and opportunities in HIV vaccine research for the next five years. The Enterprise Science Committee identified five key areas of focus for the Plan, and Working Groups of leading researchers from around the world came together to develop detailed reports to address these five areas of challenges and opportunities. 

For more details on the development of the Scientific Strategic Plan, including Reports from the five Working Groups, please click the links below.

 Right column image by Visual Science (http://visualscience.ru/en/).